Accuracy of self-reported smoking status in first trimester aneuploidy screening

Prenatal Diagnosis

Volumn 33, Issue 3, 2013, Pages 245-250

  Spencer, Kevin ^a   Cowans, Nicholas J ^a  

^a KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; COTININE; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ACCURACY; ADULT; ANEUPLOIDY; ARTICLE; CONCEPTION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MALE; PRENATAL SCREENING; PRIORITY JOURNAL; SELF REPORT; SERUM; SMOKING;

ADOLESCENT; ADULT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COTININE; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS; SELF REPORT; SMOKING; TRISOMY; YOUNG ADULT;

EID: 84874524221     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4053     Document Type: Article

References (32)

1. Kagan KO, Wright D, Baker A, et al. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;31:618-24.
2. Nicolaides KH, Spencer K, Avgidou K, et al. Multicenter study of first-trimester screening for trisomy 21 in 75821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221-6.
3. Spencer K, Souter V, Tul N, et al. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13:231-7.
4. Wright D, Spencer K, Kagan KK, et al. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol 2010;36:404-11.
5. Wright D, Kagan KO, Molina FS, et al. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008;31:376-83.
6. Spencer K, Bindra R, Nicolaides KH. Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 2003;23:851-5.
7. Kagan KO, Wright D, Spencer K, et al. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008;31:493-502.
8. Spencer K, Bindra R, Cacho AM, Nicolaides KH. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 2004;24:169-73.
9. Spencer K, Heath V, El-Sheikhah A, et al. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 2005;25:365-9.
10. Liao AW, Heath V, Kametas N, et al. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001;16:1501-4.
11. Ball S, Ekelund C, Wright D, et al. Temporal effects of maternal and pregnancy characteristics on serum PAPP-A and free beta-hCG at 7-14 weeks' gestation. Ultrasound Obstet Gynecol 2013;41:33-9.
12. Ball S, Wright D, Sodre D, et al. Temporal effect of Afro-Caribbean race on serum pregnancy-associated plasma protein-a at 9-13 weeks' gestation in screening for aneuploidies. Fetal Diagn Ther 2012;31:162-9.
13. Spencer K, Cowans NJ. Correction of first trimester biochemical aneuploidy screening markers for smoking status: influence of gestational age, maternal ethnicity and cigarette dosage. Prenat Diagn 2012. DOI: 10.1002/pd.4017.
14. Kagan KO, Frisova V, Nicolaides KH, Spencer K. Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13+6 weeks of gestation. Prenat Diagn 2007;27:849-53.
15. Cowans NJ, Spencer K. Effect of gestational age on first trimester maternal serum prenatal screening correction factors for ethnicity and IVF conception. Prenat Diagn 2013;33:56-60.
16. Spencer K. The influence of smoking on maternal serum AFP and free beta hCG levels and the impact on screening for Down syndrome. Prenat Diagn 1998;18:225-34.
17. Klebanoff MA, Levine RJ, Clemens JD, et al. Serum cotinine concentration and self-reported smoking during pregnancy. Am J Epidemiol 1998;148:259-62.
18. Klebanoff MA, Levine RJ, Morris CD, et al. Accuracy of self-reported cigarette smoking among pregnant women in the 1990s. Paediatr Perinat Epidemiol 2001;15:140-3.
19. Russell T, Crawford M, Woodby L. Measurements for active cigarette smoke exposure in prevalence and cessation studies: why simply asking pregnant women isn't enough. Nicotine Tob Res 2004;6 (Suppl 2):S141-S151.
20. Ford RP, Tappin DM, Schluter PJ, Wild CJ. Smoking during pregnancy: how reliable are maternal self reports in New Zealand? J Epidemiol Community Health 1997;51:246-51.
21. Parna K, Rahu M, Youngman LD, et al. Self-reported and serum cotinine-validated smoking in pregnant women in Estonia. Matern Child Health J 2005;9:385-92.
22. Shipton D, Tappin DM, Vadiveloo T, et al. Reliability of self reported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross sectional study. BMJ 2009;339:1-8.
23. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, et al. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987;77:1435-8.
24. Dempsey D, Jacob P, III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002;301:594-8.
25. Benowitz NL, Bernert JT, Caraballo RS, et al. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 2009;169:236-48.
26. Guidelines for interpreting cotinine levels: United States. http://www.salimetrics.com/documents/Spit_Tips_-_Cotinine_Guidelines.pdf
27. Perez-Stable EJ, Herrera B, Jacob P, III, Benowitz NL. Nicotine metabolism and intake in black and white smokers. JAMA 1998;280:152-6.
28. Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997;33:328-43.
29. Rebagliato M, Bolumar F, Florey CV, et al. Variations in cotinine levels in smokers during and after pregnancy. Am J Obstet Gynecol 1998;178:568-71.
30. Hegaard HK, Kjaergaard H, Moller LF, et al. Determination of a saliva cotinine cut-off to distinguish pregnant smokers from pregnant non-smokers. Acta Obstet Gynecol Scand 2007;86:401-6.
31. Wright D, Abele H, Baker A, Kagan KO. Impact of bias in serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A multiples of the median levels on first-trimester screening for trisomy 21. Ultrasound Obstet Gynecol 2011;38:309-13.
32. Patterson F, Benowitz N, Shields P, et al. Individual differences in nicotine intake per cigarette. Cancer Epidemiol Biomarkers Prev 2003;12:468-71.